Newsfiscal.ai
Annovis Bio to Present at 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference
· Published
Article summary
Annovis Bio announced it will deliver three presentations regarding its investigational therapy, buntanetap, at the upcoming 19th Clinical Trials on Alzheimer's Disease (CTAD) conference in November 2026.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…